← Open Payments lookup

DANNY MAYS: Open Payments

NPI 1740201672 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$600 in 23 payments from 16 companies in 2025. Trend: 2023 $626 · 2024 $750 · 2025 $600

Food & beverage: $600
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP1$117
Novo Nordisk Inc3$70
Viatris Specialty LLC2$58
Otsuka America Pharmaceutical, Inc.2$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$48
PFIZER INC.2$41
Novartis Pharmaceuticals Corporation1$31
Daiichi Sankyo Inc.1$28
Inspire Medical Systems, Inc.1$24
Baxter Healthcare1$22

Products named: AIRSUPRA, Ozempic, YUPELRI, REXULTI, XIFAXAN, PLUVICTO, INJECTAFER, PREVNAR 20.

Industry payments across NM — which companies pay providers there.